#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15824	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2178	872.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1715	1715	T	1056	T,G,A	1052,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15824	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2178	872.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	992	C,T,A	989,1,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	0	.	n	.	0	T695C	SNP	695	695	T	1275	1275	C	1001	C	1001	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	2218	2218	G	973	G,T	972,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2551	2551	C	883	C,A	882,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	0	.	n	.	0	C2194T	SNP	2194	2194	C	2774	2774	T	800	T	800	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3177	3177	T	950	T,G	948,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26188	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4055	805.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2625	2625	A	801	A	801	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2172	folP	852	852	100.0	folP.l15.c4.ctg.1	1952	138.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1236	1238	CGC	217;215;214	C;G;C	217;215;214	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5114	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	169.6	1	SNP	p	S91F	0	.	.	271	273	TCC	756	758	TCC	205;205;205	T;C,A;C,A	205;204,1;204,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5114	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	169.6	1	SNP	p	D95G	0	.	.	283	285	GAC	768	770	GAC	213;215;216	G,T;A;C	212,1;215;216	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5114	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	169.6	1	SNP	p	D95N	0	.	.	283	285	GAC	768	770	GAC	213;215;216	G,T;A;C	212,1;215;216	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1982	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1824	135.4	1	SNP	p	G45D	1	.	.	133	135	GAC	763	765	GAC	221;225;223	G;A,T;C	221;224,1;223	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1054	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	1353	97.0	0	.	n	.	0	T10C	SNP	10	10	T	564	564	C	191	C	191	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1054	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	1353	97.0	0	.	n	.	0	A197.	DEL	197	197	A	750	750	A	210	A	210	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1692	1694	ATC	234;236;233	A,C;T,A;C	233,1;235,1;233	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1845	1847	GCA	242;240;239	G;C;A	242;240;239	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2328	2330	ATT	266;268;262	A;T;T	266;268;262	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	1	SNP	p	D86N	0	.	.	256	258	GAC	798	800	GAC	227;223;222	G;A,T;C	227;221,2;222	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	1	SNP	p	S87W	0	.	.	259	261	AGT	801	803	AGT	226;231;232	A,G;G,A;T,G	225,1;230,1;231,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	1	SNP	p	S87R	0	.	.	259	261	AGT	801	803	AGT	226;231;232	A,G;G,A;T,G	225,1;230,1;231,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	1	SNP	p	S87I	0	.	.	259	261	AGT	801	803	AGT	226;231;232	A,G;G,A;T,G	225,1;230,1;231,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5232	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3428	190.2	1	SNP	p	S88P	0	.	.	262	264	TCC	804	806	TCC	233;234;235	T,G,A;C;C,T	231,1,1;234;234,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4302	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3095	173.4	0	.	p	.	0	G168S	NONSYN	502	504	GGC	1040	1042	AGC	216;217;215	A;G,A;C,A	216;216,1;214,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4302	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3095	173.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1766	1768	GGC	233;231;232	G;G,T;C	233;230,1;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1442	1444	GCA	274;276;275	G;C;A	274;276;275	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1445	1447	ATC	276;273;273	A,T;T,G;C,A	275,1;272,1;271,2	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1457	1459	GTG	268;270;271	G,A;T,C;G,T	267,1;269,1;270,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1457	1459	GTG	268;270;271	G,A;T,C;G,T	267,1;269,1;270,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1961	1963	ACC	272;270;265	A;C;C,A	272;270;264,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2015	2017	GCG	240;244;243	G;C;G,T,C	240;244;241,1,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2015	2017	GCG	240;244;243	G;C;G,T,C	240;244;241,1,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2138	2140	GGT	312;313;314	G;G;T	312;313;314	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2147	2149	GGC	311;311;310	G;G;C	311;311;310	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2809	209.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2165	2167	CCG	302;301;299	C;C;G	302;301;299	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5494	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3402	201.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1772	1774	CCG	229;228;231	C;C;G,T	229;228;230,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2230	porA	1146	1146	99.65	porA.l15.c17.ctg.1	2124	130.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	576	578	GGC	163;164;165	G,A;G;C	162,1;164;165	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2230	porA	1146	1146	99.65	porA.l15.c17.ctg.1	2124	130.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	758	758	C	183	C,A	182,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3186	porB1b	1047	1047	99.81	porB1b.l6.c30.ctg.1	1857	212.1	0	.	p	.	0	G120D	NONSYN	358	360	GGC	770	772	GAC	266;270;271	G,C;A,C;C,G	265,1;268,2;270,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3186	porB1b	1047	1047	99.81	porB1b.l6.c30.ctg.1	1857	212.1	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	773	775	AAC	271;274;272	A,G;A;C,A	270,1;274;271,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10854	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5287	255.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2243	2245	CAT	287;286;286	C,A;A;TAAA,TAA	286,1;286;270,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1596	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1501	132.5	1	SNP	p	V57M	1	.	.	169	171	ATG	807	809	ATG	270;269;265	A;T;G	270;269;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
